87 related articles for article (PubMed ID: 1382732)
1. [Demonstration of thymidine phosphorylase activity in human healthy, adenomatous and cancerous prostate].
Touffet S; Gayet G; Sampérez S; Jouan P
Bull Cancer; 1992; 79(2):151-9. PubMed ID: 1382732
[TBL] [Abstract][Full Text] [Related]
2. [Determination of thymidine phosphorylase in adenoma and cancer of the human prostate].
Touffet S; Samperez S; Jouan P
C R Seances Soc Biol Fil; 1989; 183(1):26-32. PubMed ID: 2476202
[TBL] [Abstract][Full Text] [Related]
3. Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells.
Kikuno N; Moriyama-Gonda N; Yoshino T; Yoneda T; Urakami S; Terashima M; Yoshida M; Kishi H; Shigeno K; Shiina H; Igawa M
Cancer Res; 2004 Oct; 64(20):7526-32. PubMed ID: 15492279
[TBL] [Abstract][Full Text] [Related]
4. Distribution of thymidine phosphorylase activity in gastric carcinoma and adjacent normal gastric tissue.
Sugiyama A; Maruta F; Tsuzuki S; Murakami M; Kawasaki S
Hepatogastroenterology; 2002; 49(48):1734-6. PubMed ID: 12397781
[TBL] [Abstract][Full Text] [Related]
5. Increased migration by stimulation of thymidine phosphorylase in endothelial cells of different origin.
Bijnsdorp IV; Vrijland K; Vroling L; Fukushima M; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):482-7. PubMed ID: 20544542
[TBL] [Abstract][Full Text] [Related]
6. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
Sharief FS; Mohler JL; Sharief Y; Li SS
Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase (ODC) expression pattern in human prostate tissues and ODC transgenic mice.
Young L; Salomon R; Au W; Allan C; Russell P; Dong Q
J Histochem Cytochem; 2006 Feb; 54(2):223-9. PubMed ID: 16234506
[TBL] [Abstract][Full Text] [Related]
8. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
[TBL] [Abstract][Full Text] [Related]
9. Preliminary report on the effect of medroxyprogesterone acetate on human prostate LDH-isoenzymes.
Rutten J; van Sande M; Van Camp K
Acta Urol Belg; 1977 Jan; 45(1):28-30. PubMed ID: 67788
[No Abstract] [Full Text] [Related]
10. Distribution of cathepsin D granules in normal and pathologic conditions in human prostate.
Islam AH; Kato H; Nishizawa O; Hayama M
Hinyokika Kiyo; 2002 Nov; 48(11):647-52. PubMed ID: 12512135
[TBL] [Abstract][Full Text] [Related]
11. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
Verlooy J; van Sande M; Van Camp K
Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
[No Abstract] [Full Text] [Related]
12. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
Durocher Y; Chapdelaine A; Chevalier S
Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
[TBL] [Abstract][Full Text] [Related]
13. [Studies on 5-FU concentration and thymidine phosphorylase activity in tissues of patients with colorectal cancer after SF-SP administration].
Yamada K; Hase S; Yoshimura A; Haruyama K; Katsura Y; Sameshima T; Niwa K; Ishizawa T; Shimazu H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2333-7. PubMed ID: 2260869
[TBL] [Abstract][Full Text] [Related]
14. Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.
Kataoka A; Yuasa T; Kageyama S; Iwaki H; Higuchi K; Tanaka T; Okada Y; Yoshiki T
Oncol Rep; 2005 Apr; 13(4):597-600. PubMed ID: 15756429
[TBL] [Abstract][Full Text] [Related]
15. Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues.
Oliveira OL; Koff WJ; Muraro F; Santos EB; Gomes Soares DF; Trindade VM
Clin Chim Acta; 2008 May; 391(1-2):36-40. PubMed ID: 18328817
[TBL] [Abstract][Full Text] [Related]
16. Hormone regulation of human prostate in organ culture.
Nevalainen MT; Härkönen PL; Valve EM; Ping W; Nurmi M; Martikainen PM
Cancer Res; 1993 Nov; 53(21):5199-207. PubMed ID: 7693334
[TBL] [Abstract][Full Text] [Related]
17. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
[TBL] [Abstract][Full Text] [Related]
18. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
19. Lactate dehydrogenase isoenzymes in benign and malignant prostatic tissues.
Mazzuca A; Lalanne GM
Boll Soc Ital Biol Sper; 1980 Apr; 56(7):690-2. PubMed ID: 6160867
[TBL] [Abstract][Full Text] [Related]
20. Lactic dehydrogenase isozymes in benign and malignant prostatic tissues.
Srinivasan V; Keil E; Villalba R; Baron T; Clark SS
Invest Urol; 1973 Nov; 11(3):244-7. PubMed ID: 4127178
[No Abstract] [Full Text] [Related]
[Next] [New Search]
